Overexpression of METTL3 in glioblastoma stem cells (GSCs) has been correlated with a poor prognosis for glioblastoma and its silencing in GSCs has been shown to reduce tumour growth in vivo.55 This evidence concerns the gene METTL3 and glioblastoma.